Dr Joanna Achinger-Kawecka
Dr Joanna Achinger-Kawecka’s research focuses on investigating the role of the 3D epigenome in cancer, particularly in driving tumour progression and treatment resistance in breast and prostate cancer. Joanna completed her PhD at the University of Tuebingen, Germany, investigating microRNA signatures as predictive biomarkers for breast cancer treatment outcome.
Following her PhD, Joanna joined the laboratory of Professor Susan Clark at the Garvan Institute of Medical Research, where she established cutting-edge experimental and computational approaches to study the 3D genome organisation during development and progression of cancer.
Awards
- 2024NHMRC Ideas Grant
- 2023PCFA Priority Impact Research Award Young Investigator Award
- 2023St Vincent's Campus Research Symposium Rising Star Award
- 2022UNSW Cancer Theme EMCR Seed Grant
- 2021NBCF Fellowship (2021 - 2024)
- 2020Cancer Council NSW Project Grant (2020 - 2022)
- 2020UNSW Cellular Genomics Futures Institute Seed Grant (2020 - 2021)
- 2019EMBO Travel Award
- 2019Estee Lauder Companies’ Breast Cancer Campaign Award
- 2018CASS Foundation Travel Grant
- 2017The Ian Potter Foundation Travel Grant
- 2016Heliflite Young Explorer Award
- 2011FP7 Marie Curie Initial Training Network “Fighting Drug Failure” Fellowship
Selected publications
See all publications- 2024Nucleic Acids Research10.1093/nar/gkae530
Machine learning enables pan-cancer identification of mutational hotspots at persistent CTCF binding sites.
- 2024BMC Genomics10.1186/s12864-024-10027-5
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling.
- 2024Nature Structural & Molecular Biology10.1038/s41594-023-01181-7
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.
- 2023Nature Cancer10.1038/s43018-023-00681-1
The 2023 generation.
- 2023Science Advances10.1126/sciadv.abp8314
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma.